Insider Activity Highlights a Shift in Jayme Mendal’s Trading Cadence
EverQuote’s most recent Form 4 filing, dated September 15, reveals that CEO and President Mendel Jayme executed a series of Rule 10b5‑1 trades that illustrate a deliberate management of his equity stake. The filing shows a purchase of 11,406 shares of Class A common stock at the market price of $23.34 (the filing lists $0.00 because the transaction was pre‑authorized). This transaction increased his net position to 612,141 shares.
Concurrently, Jayme sold 20,981 shares at an average price of $24.27 and another 11,406 option‑derived shares at $6.96, reducing his holdings to 591,160 shares. The total volume moved in the single day represented roughly 10 % of his stake, a modest proportion when viewed against his overall holdings.
What the Pattern Means for Investors
The back‑to‑back buy–sell cycle, orchestrated under a pre‑established 10b5‑1 plan, indicates that Jayme is actively managing exposure rather than reacting to short‑term market sentiment. The trades are evenly spaced, and their volume is modest relative to the CEO’s total stake. For shareholders, this suggests a disciplined approach to diversification or rebalancing rather than speculation on price swings.
EverQuote’s share price has fallen 10.24 % year‑to‑date, trading near its 52‑week low. The CEO’s recent purchases may therefore reflect a strategy to lock in favorable pricing before a potential rebound. Importantly, the absence of any sudden, large‑scale sales in the last quarter provides reassurance that there is no immediate liquidity pressure or hidden alarm.
Mendel Jayme: A Profile Built on Consistency
Since 2024, Jayme has consistently sold large blocks of shares in the first quarter, often at prices below the market average, and purchased smaller blocks during the summer and fall. His most substantial sale occurred in February 2026 (23,755 shares at $14.74) when the stock hovered near its 52‑week low. Conversely, his largest purchase came in February 2026 (121,108 shares at $0.00), a block bought at a deep discount under his equity‑grant plan. These actions demonstrate a long‑term view: accumulating shares when the market is depressed and offloading them as valuations rise, aligning his personal interests with those of shareholders.
The current 10b5‑1 buy–sell cycle is a continuation of this disciplined, rule‑based strategy rather than a reaction to market noise.
Company‑Wide Insider Activity: A Mixed Picture
Other top executives have also been active. CFO Sanborn Joseph and CTO David Brainard executed multiple sell trades throughout the year, often near the company’s 52‑week low. Social‑media buzz at 58.82 % indicates heightened attention, but the sentiment score (+12) remains neutral. The modest weekly decline of 2.55 % and a broader monthly slide of 6.65 % suggest that the market may still be pricing in upcoming growth potential, particularly as EverQuote expands its auto‑insurance marketplace.
Investors should monitor future Rule 10b5‑1 transactions, as they often presage strategic moves—whether a shift in product focus or an upcoming capital raise.
Bottom Line for Investors
Jayme Mendel’s disciplined trading pattern, combined with the company’s recent sales of options and restricted‑stock units, points to prudent management of personal exposure rather than a signal of impending distress. The 10b5‑1 buy and sell on September 15 reflect a balanced approach to risk in a volatile market. For long‑term investors, this activity underscores the CEO’s alignment with shareholder interests and suggests that EverQuote’s management remains focused on driving growth in the interactive media and services space, even as the stock navigates a challenging valuation environment.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026‑09‑15 | Mendal Jayme (CEO & President) | Buy | 11,406.00 | N/A | Class A Common Stock |
| 2026‑09‑15 | Mendal Jayme (CEO & President) | Sell | 20,981.00 | 24.27 | Class A Common Stock |
| 2026‑09‑15 | Mendal Jayme (CEO & President) | Sell | 11,406.00 | 6.96 | Stock Option (right to buy) |




